MELBOURNE, Australia, April 30, 2025 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, Telix, the Company) today announces that its prostate cancer PET [1] imaging agent ...

Mohammad Mahmoud, MD, MS, reviews important updates in metastatic prostate cancer presented at AUA 2025, including promising ...

A new means of prostate cancer screening could emerge as an alternative to the PSA test, which has long been the first-line option. Using machine learning, a form of artificial intelligence ...

From 2010 to 2024, the rate of surgeries declined more than fivefold in patients with pathologic grade group 1 (pGG1) prostate cancer, a cohort study found. The small proportion that were ...

Prostate cancer is one of the leading global causes of death among men, with hundreds of thousands succumbing to the malignant condition each year and over a million new cases diagnosed annually.

GlaxoSmithKline and AstraZeneca will go head-to-head with new data on their PARP inhibitor drugs this weekend, as the European Society of Medical Oncology (ESMO) congress in Barcelona gets underway.

Buoyed by data from a trial of its T-cell engager (TCE) therapy in prostate cancer that almost tripled ... and efficacy results at last year’s ESMO congress. Meanwhile, Janux also reported ...

can significantly improve the accuracy of skin cancer diagnoses. 9 In a study conducted at Stanford Medicine, AI algorithms trained on thousands of skin images helped health care practitioners ...

Mouth cancer may look like white patches, red patches, or tongue sores. Unlike noncancerous lesions, they’re not typically painful when they first appear. Oral cancer is a type of cancer that ...

Less than a year after his coronation, the King was diagnosed with an undisclosed cancer, which was found while he was undergoing treatment for a separate issue relating to an enlarged prostate.

Some research has also investigated whether reishi could be beneficial for prostate and colorectal cancer due to its effects on inflammation and certain signaling pathways involved in cancer ...